INVESTMENTS (Narrative) (Details) - USD ($) $ in Thousands |
12 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Jan. 01, 2023 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Mar. 31, 2026 |
Dec. 31, 2019 |
|||||
| Investments [Line Items] | ||||||||||
| Total investment | $ 357 | $ 277 | ||||||||
| Realized Investment Gain (Loss) | 0 | $ 0 | $ 707 | |||||||
| Arrow Ecology & Engineering Overseas (1999) [Member] | ||||||||||
| Investments [Line Items] | ||||||||||
| Price paid for debt | $ 4,146 | |||||||||
| Ownership interest | 22.60% | [1] | 22.60% | [1] | 22.60% | |||||
| Total investment | $ 1,750 | |||||||||
| Guaranteed to repurchase full investment | 1,750 | |||||||||
| Arrow Ecology & Engineering Overseas (1999) [Member] | Subsequent Event [Member] | ||||||||||
| Investments [Line Items] | ||||||||||
| Total investment | $ 500 | |||||||||
| Manuka, Inc. (Previously Artemis Therapeutics, Inc.) [Member] | ||||||||||
| Investments [Line Items] | ||||||||||
| Market value | 0 | $ 0 | ||||||||
| Capital Fund Aims To Invest In Private Emerging Companies With Focus On Consumer, Commerce And Technology Companies [Member] | ||||||||||
| Investments [Line Items] | ||||||||||
| Committed to invest | $ 100 | |||||||||
| Sardinai [Member] | ||||||||||
| Investments [Line Items] | ||||||||||
| Percentage of investment sold | 85.00% | |||||||||
| Investment sold | $ 756 | |||||||||
| ||||||||||